Position in INSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$212,706
-$352,909 QoQ
Shares Held
1,995
-42.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#484
of 666 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026INSIGNEO ADVISORY SERVICES, LLC holds $3,685,699 across 13 Biotechnology names. INSM ranks #7 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
10,847 | $591,595 | |
| 2 | ATAI |
AtaiBeckley Inc.
|
104,252 | $549,407 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
958 | $475,866 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
742 | $462,666 | |
| 5 | DFTX |
Definium Therapeutics, Inc.
|
6,341 | $298,280 | |
| 6 | ONC |
BeOne Medicines Ltd.
|
1,010 | $287,819 | |
| 7 | INSM |
INSMED Inc
This page
|
1,995 | $212,706 | |
| 8 | NTLA |
Intellia Therapeutics, Inc.
|
12,000 | $203,040 |
All Filings in INSM
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $212,706 | 1,995 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $565,615 | 3,459 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $459,639 | 2,641 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $345,047 | 2,396 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||